The role of cell-free DNA in fibrinolysis for intraventricular hemorrhage

被引:6
|
作者
Xie, Fangke [1 ]
Tan, Qiang [2 ]
Yu, Anyong [1 ]
Guo, Peiwen [2 ]
Wang, Ling [2 ]
Zeng, Zongwei [2 ]
Liang, Liang [2 ]
Xian, Jishu [2 ]
Feng, Hua [2 ]
Chen, Zhi [2 ]
机构
[1] Zunyi Med Univ, Affiliated Hosp, Dept Emergency, Zunyi, Peoples R China
[2] Third Mil Med Univ, Army Med Univ, Southwest Hosp, Dept Neurosurg, Chongqing, Peoples R China
基金
中国国家自然科学基金;
关键词
intraventricular hemorrhage; tissue plasminogen activator; neutrophil extracellular traps; cell-free DNA; fibrinolysis; vascular disorders; NEUTROPHIL EXTRACELLULAR TRAPS; TISSUE-PLASMINOGEN ACTIVATOR; CITRULLINATED HISTONE H3; CANINE MODEL; BLOOD-CLOT; UROKINASE; HEMATOMA; LYSIS; THERAPY;
D O I
10.3171/2020.7.JNS201429
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
OBJECTIVE Tissue plasminogen activator (tPA) fibrinolysis did not improve functional outcomes of patients with intraventricular hemorrhage (IVH), largely because of the unsatisfactory clot clearance. The presence of neutrophil extracellular traps (NETs) within the clot has been confirmed to impair tPA fibrinolysis, but the mechanism has been unclear. The authors hypothesized that cell-free DNA (cfDNA), the main framework of NETs, might be the important reason for the fibrinolysis resistance, and they validated the hypothesis, hoping to provide a new target to promote intraventricular fibrinolysis. METHODS First, cfDNA was detected in IVH clots by immunofluorescence staining in a rat model of IVH. Second, after blood (with or without exogenous cfDNA) intraventricular injection, IVH rats were given intraventricular infusion of 2 mu l of saline, tPA, or tPA + DNase1 randomly. Then, the ventricular volume, animal behavior, and reactive astrocyte proliferation were assessed. Third, the IVH clots were collected for fibrinolysis assay in vitro. Finally, the effects of exogenous cfDNA in IVH were evaluated. RESULTS The presence of cfDNA in clots was observed as early as 1 hour after IVH. Compared with the whole-blood model, blood + cfDNA caused more severe ventricular dilation (day 7: blood 32.47 +/- 2.096 mm(3) vs blood + DNA 40.09 +/- 2.787 mm(3), p < 0.05), increased fibrinolysis resistance to tPA (day 7: tPA + DNA 26.04 +/- 1.318 mm(3) vs tPA 22.15 +/- 1.706 mm(3), p < 0.05), and further deteriorated the functional defects in rats (blood vs blood + DNA, p < 0.05). Degradation of cfDNA by DNase1 further enhanced the fibrinolysis effects on relieving the ventricular dilation (day 7: tPA + DNase1 11.67 +/- 2.023 mm(3) vs tPA, p < 0.05), improving the functional outcome (tPA vs tPA + DNase1, p < 0.05) and reducing periventricular astrocyte proliferation. CONCLUSIONS cfDNA impaired tPA fibrinolysis for IVH, and degradation of cfDNA may be a new target to improve this condition.
引用
收藏
页码:1105 / 1112
页数:8
相关论文
共 50 条
  • [1] Intraventricular hemorrhage treated with intraventricular fibrinolysis. A 10-year experience
    Castano Avila, S.
    Corral Lozano, E.
    Vallejo De La Cueva, A.
    Maynar Moliner, J.
    Martin Lopez, A.
    Fonseca San Miguel, F.
    Urturi Matos, J. A.
    Manzano Ramirez, A.
    MEDICINA INTENSIVA, 2013, 37 (02) : 61 - 66
  • [2] Urokinase versus Alteplase for intraventricular hemorrhage fibrinolysis
    Gaberel, Thomas
    Montagne, Axel
    Lesept, Flavie
    Gauberti, Maxime
    Lemarchand, Eloise
    Orset, Cyrille
    Goulay, Romain
    Bertrand, Thomas
    Emery, Evelyne
    Vivien, Denis
    NEUROPHARMACOLOGY, 2014, 85 : 158 - 165
  • [3] Intraventricular hemorrhage related to AVM rupture: Description, outcomes and impact of intraventricular fibrinolysis
    Gilard, Vianney
    Metayer, Thomas
    Gakuba, Clement
    Langlois, Olivier
    Proust, Francois
    Emery, Evelyne
    Gaberel, Thomas
    CLINICAL NEUROLOGY AND NEUROSURGERY, 2018, 164 : 92 - 96
  • [4] Intraventricular Fibrinolysis for Intracerebral Hemorrhage with Severe Ventricular Involvement
    Staykov, Dimitre
    Bardutzky, Juergen
    Huttner, Hagen B.
    Schwab, Stefan
    NEUROCRITICAL CARE, 2011, 15 (01) : 194 - 209
  • [5] Intraventricular Fibrinolysis and Lumbar Drainage for Ventricular Hemorrhage
    Staykov, Dimitre
    Huttner, Hagen B.
    Struffert, Tobias
    Ganslandt, Oliver
    Doerfler, Arnd
    Schwab, Stefan
    Bardutzky, Juergen
    STROKE, 2009, 40 (10) : 3275 - 3280
  • [6] Cell-Free DNA Modulates Clot Structure and Impairs Fibrinolysis in Sepsis
    Gould, Travis J.
    Vu, Trang T.
    Stafford, Alan R.
    Dwivedi, Dhruva J.
    Kim, Paul Y.
    Fox-Robichaud, Alison E.
    Weitz, Jeffrey I.
    Liaw, Patricia C.
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2015, 35 (12) : 2544 - 2553
  • [7] Shunt Dependence after Intraventricular Hemorrhage and Intraventricular Fibrinolysis with uPA versus rt-PA
    Covrig, Raul-Ciprian
    Schellinger, Peter D.
    Glahn, Joerg
    Alomari, Ali
    Schmieder, Kirsten
    Wiese, M.
    Knappe, Ulrich Johannes
    JOURNAL OF NEUROLOGICAL SURGERY PART A-CENTRAL EUROPEAN NEUROSURGERY, 2023, 84 (03) : 255 - 260
  • [8] Intraventricular Fibrinolysis Versus External Ventricular Drainage Alone in Intraventricular Hemorrhage A Meta-Analysis
    Gaberel, Thomas
    Magheru, Cristian
    Parienti, Jean-Jacques
    Huttner, Hagen Bernhard
    Vivien, Denis
    Emery, Evelyne
    STROKE, 2011, 42 (10) : 2776 - U165
  • [9] Intraventricular fibrinolysis for severe aneurysmal intraventricular hemorrhage: a randomized controlled trial and meta-analysis
    Litrico, Stephane
    Almairac, Fabien
    Gaberel, Thomas
    Ramakrishna, Rohan
    Fontaine, Denys
    Sedat, Jacques
    Lonjon, Michel
    Paquis, Philippe
    NEUROSURGICAL REVIEW, 2013, 36 (04) : 523 - 530
  • [10] Fibrinolysis for Intraventricular Hemorrhage An Updated Meta-Analysis and Systematic Review of the Literature
    Khan, Nickalus R.
    Tsivgoulis, Georgios
    Lee, Siang Liao
    Jones, G. Morgan
    Green, Cain S.
    Katsanos, Aristeidis H.
    Klimo, Paul, Jr.
    Arthur, Adam S.
    Elijovich, Lucas
    Alexandrov, Andrei V.
    STROKE, 2014, 45 (09) : 2662 - +